THYCAN 2018

THYCAN 2018

31st March 2018, Guwahati  I  7th April 2018, New Delhi

BCPBF – The Cancer Foundation is scheduled to host a Symposium on ‘Best Practice Treatment of Differentiated Thyroid Cancer in India’ – THYCAN 2018. Although the incidence of Thyroid Cancer in India amongst all cancers is only 0.1% to 0.2% (ICMR), yet its excellent prognosis after appropriate treatment bestows on it the epithet of CURABLE CANCER.

The focused event to be held at Guwahati and New Delhi, has the confirmed participation of eminent Surgical/Medical Oncologists, Head & Neck/ENT Surgeons, Nuclear Medicine experts, Endocrinologists from India.

Lecture I

radioiodine ablation for differentiated thyroid cancer – current perspective

Lecture II

minimally invasive surgical technique for differentiated thyroid cancer

Lecture III

targeted therapy for iodine refractory differentiated thyroid cancer

CHIEF GUESTS

DR AMAL CHANDRA KATAKI DIRECTOR

Dr. B. Borooah Cancer Institute Regional Cancer Centre Guwahati, ASSAM

DR. SUDHIR GUPTA

Addl. Deputy Director General, Ministry of Health & Family Welfare, Government of India, NEW DELHI

CHAIRPERSONS

DR S.H. ADVANI,

Director of Medical Oncology, Haematology Jaslok Hospital & Medical Research Institute, Mumbai

DR.B.A.KRISHNA,

Director Nuclear Medicine and PET imaging, Lilavati Hospital

Endocrine Cancer Specialist, Raheja Hospital, Mumbai.

SPEAKERS

GUWAHATI

PROFESSOR C. S. BAL

Prof & Head, Nuclear Medicine, AIIMS, New Delhi

DR SAMEER KAUL,

Sr. Consultant Surgical Oncology & Robotics, Apollo Cancer Institute, New Delhi

DR. GOVIND BABU

Prof. Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore

NEW DELHI

PROFESSOR C. S. BAL

Prof & Head, Nuclear Medicine, AIIMS, New Delhi

DR SAMEER KAUL,

Sr. Consultant Surgical Oncology & Robotics, Apollo Cancer Institute, New Delhi

DR. GOVIND BABU

Prof. Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore

Supported By:

thumbnail_Fusion Logo 1